pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
PUBLIC COMPANY
save

$LLYELI LILLY & Co

$LLY1195.14+1.27%
Indianapolis, IN, USupdated 1h ago

Eli Lilly was an American Union Army officer, pharmacist, chemist, and businessman who founded Eli Lilly and Company.

Website ↗SEC EDGAR ↗Yahoo Finance ↗
community read0 votes
pipeline
8
marketed
1
phase 3
0
catalysts ytd
10
approvals ytd
7
recalls ytd
0

Pipeline(8)

pipeline depth8 products
Marketed: 1Unknown: 7
1Marketed7Unknown
Marketed
ZEPBOUND
type 2 diabetes
Glucagon-like peptide 1 receptorGastric inhibitory polypeptide receptor
drug
EBGLYSS
1 INDICATIONS AND USAGE EBGLYSS is indicated for the trea…
Interleukin-13
drug
FOUNDAYO
1 INDICATIONS AND USAGE FOUNDAYO TM is indicated in combi…
drug
INLURIYO
1 INDICATIONS AND USAGE INLURIYO is indicated for the tre…
drug
MOUNJARO
1 INDICATIONS AND USAGE MOUNJARO ® is indicated as an adj…
Glucagon-like peptide 1 receptorGastric inhibitory polypeptide receptor
drug
OMVOH
1 INDICATIONS AND USAGE OMVOH is indicated for the treatm…
Interleukin-23
drug
RETEVMO
1 INDICATIONS AND USAGE RETEVMO ® is a kinase inhibitor i…
Coiled-coil domain-containing protein 6/Tyrosine-protein kinase receptor RETProto-oncogene tyrosine-protein kinase receptor Ret
drug
TRULICITY
1 INDICATIONS AND USAGE TRULICITY ® is indicated: As an a…
Glucagon-like peptide 1 receptor

📅 Upcoming

Oct 29, 2026
earnings
$LLY1195.14+1.27%
in 2mo
ELI LILLY & Co earnings
ELI LILLY & Co
→

🕒 Recent(90d)

earnings (1)
Aug 5, 2026
earnings
$LLY1195.14+1.27%
12d ago
ELI LILLY & Co earnings
ELI LILLY & Co
→
view all catalysts →

Insider activity

source: SEC Form 4
routine RSU / option mechanics (6)
  • Apr 20, 26grantLUCIANO JUAN R · director17 sh
  • Apr 20, 26grantAlvarez Ralph · director13 sh
  • Apr 20, 26grantFyrwald J Erik · director11 sh
  • Apr 20, 26grantSulzberger Gabrielle · director5 sh
  • Mar 16, 26grantLUCIANO JUAN R · director16 sh
  • Mar 16, 26grantAlvarez Ralph · director13 sh
🐶 Hiring Signal
next earnings Oct 29, 2026
724 open roles at ELI LILLY & Co →

Where ELI LILLY & Co is staffing up — a leading indicator of pipeline and commercial priorities.

therapeutic areaCNS / Neuroscience 40Oncology 28Cardiovascular 23Immunology & Inflammation 14Dermatology 12Metabolic 5
departmentR&D / Discovery 186IT & Engineering 107Manufacturing / CMC 69Quality 40Medical Affairs 24Regulatory 21

News

  • Lilly to invest extra $4.5B across Indiana manufacturing
    The Indianapolis-based company expanded its spend to ensure it can meet growing demand for its weight-loss drugs.
    biopharma_dive · 3mo ago
identifiers
ticker
$LLY
SEC CIK
0000059478
country
US
source
sec_tickers
top tags
Obesity1Pulmonology1
mentioned in
1news items
entity-linker matched
Data sources
SEC EDGAR · openFDA
last refreshed 6m ago
Found something off?
🐶 something off?

Report a data issue

Tell Bork what looks wrong — wrong sponsor, stale phase, mislinked ticker, anything. We’ll triage and fix.

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?